These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

852 related items for PubMed ID: 26626103

  • 1. In silico multiple-targets identification for heme detoxification in the human malaria parasite Plasmodium falciparum.
    Phaiphinit S, Pattaradilokrat S, Lursinsap C, Plaimas K.
    Infect Genet Evol; 2016 Jan; 37():237-44. PubMed ID: 26626103
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of hemozoin formation in Plasmodium falciparum trophozoite extracts by heme analogs: possible implication in the resistance to malaria conferred by the beta-thalassemia trait.
    Martiney JA, Cerami A, Slater AF.
    Mol Med; 1996 Mar; 2(2):236-46. PubMed ID: 8726466
    [Abstract] [Full Text] [Related]

  • 3. Antimalarial drugs inhibiting hemozoin (beta-hematin) formation: a mechanistic update.
    Kumar S, Guha M, Choubey V, Maity P, Bandyopadhyay U.
    Life Sci; 2007 Feb 06; 80(9):813-28. PubMed ID: 17157328
    [Abstract] [Full Text] [Related]

  • 4. [Transport proteins as drug targets in Plasmodium falciparum. New perspectives in the treatment of malaria].
    Ellekvist P, Colding H.
    Ugeskr Laeger; 2006 Mar 27; 168(13):1314-7. PubMed ID: 16579884
    [Abstract] [Full Text] [Related]

  • 5. Exploring Heme and Hemoglobin Binding Regions of Plasmodium Heme Detoxification Protein for New Antimalarial Discovery.
    Gupta P, Mehrotra S, Sharma A, Chugh M, Pandey R, Kaushik A, Khurana S, Srivastava N, Srivastava T, Deshmukh A, Panda A, Aggarwal P, Bhavesh NS, Bhatnagar RK, Mohmmed A, Gupta D, Malhotra P.
    J Med Chem; 2017 Oct 26; 60(20):8298-8308. PubMed ID: 28949547
    [Abstract] [Full Text] [Related]

  • 6. Double-drug development against antioxidant enzymes from Plasmodium falciparum.
    Biot C, Dessolin J, Grellier P, Davioud-Charvet E.
    Redox Rep; 2003 Oct 26; 8(5):280-3. PubMed ID: 14962365
    [Abstract] [Full Text] [Related]

  • 7. Modeling metabolism and stage-specific growth of Plasmodium falciparum HB3 during the intraerythrocytic developmental cycle.
    Fang X, Reifman J, Wallqvist A.
    Mol Biosyst; 2014 Oct 26; 10(10):2526-37. PubMed ID: 25001103
    [Abstract] [Full Text] [Related]

  • 8. Antimalarial drug targets in Plasmodium falciparum predicted by stage-specific metabolic network analysis.
    Huthmacher C, Hoppe A, Bulik S, Holzhütter HG.
    BMC Syst Biol; 2010 Aug 31; 4():120. PubMed ID: 20807400
    [Abstract] [Full Text] [Related]

  • 9. Heme Detoxification in the Malaria Parasite: A Target for Antimalarial Drug Development.
    de Villiers KA, Egan TJ.
    Acc Chem Res; 2021 Jun 01; 54(11):2649-2659. PubMed ID: 33982570
    [Abstract] [Full Text] [Related]

  • 10. Novel Plasmodium falciparum metabolic network reconstruction identifies shifts associated with clinical antimalarial resistance.
    Carey MA, Papin JA, Guler JL.
    BMC Genomics; 2017 Jul 19; 18(1):543. PubMed ID: 28724354
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Antimalarial drugs and drug targets specific to fatty acid metabolic pathway of Plasmodium falciparum.
    Qidwai T, Khan F.
    Chem Biol Drug Des; 2012 Aug 19; 80(2):155-72. PubMed ID: 22487082
    [Abstract] [Full Text] [Related]

  • 13. Metabolomic Profiling of the Malaria Box Reveals Antimalarial Target Pathways.
    Allman EL, Painter HJ, Samra J, Carrasquilla M, Llinás M.
    Antimicrob Agents Chemother; 2016 Nov 19; 60(11):6635-6649. PubMed ID: 27572391
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The Metabolite Repair Enzyme Phosphoglycolate Phosphatase Regulates Central Carbon Metabolism and Fosmidomycin Sensitivity in Plasmodium falciparum.
    Dumont L, Richardson MB, van der Peet P, Marapana DS, Triglia T, Dixon MWA, Cowman AF, Williams SJ, Tilley L, McConville MJ, Cobbold SA.
    mBio; 2019 Dec 10; 10(6):. PubMed ID: 31822583
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Macrolides rapidly inhibit red blood cell invasion by the human malaria parasite, Plasmodium falciparum.
    Wilson DW, Goodman CD, Sleebs BE, Weiss GE, de Jong NW, Angrisano F, Langer C, Baum J, Crabb BS, Gilson PR, McFadden GI, Beeson JG.
    BMC Biol; 2015 Jul 18; 13():52. PubMed ID: 26187647
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. In Silico Knockout Screening of Plasmodium falciparum Reactions and Prediction of Novel Essential Reactions by Analysing the Metabolic Network.
    Oyelade J, Isewon I, Uwoghiren E, Aromolaran O, Oladipupo O.
    Biomed Res Int; 2018 Jul 18; 2018():8985718. PubMed ID: 29789805
    [Abstract] [Full Text] [Related]

  • 20. Network-based assessment of the selectivity of metabolic drug targets in Plasmodium falciparum with respect to human liver metabolism.
    Bazzani S, Hoppe A, Holzhütter HG.
    BMC Syst Biol; 2012 Aug 31; 6():118. PubMed ID: 22937810
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 43.